Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MI

Journal of Lipid Research

Volumn 49, Issue 5, 2008, Pages 1034-1038

  Seidelmann, Sara Bretschger ^a,b   Li, N ^a,b   Shen, Gong Qing ^a,b   Topol, Eric J ^c   Wang, Qing Kenneth ^a,b,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Coronary artery disease myocardial infarction; Genetics; Linkage; Metabolic syndrome

Indexed keywords

TRIACYLGLYCEROL;

ADULT; CAUCASIAN; CHROMOSOME 1P; CONFERENCE PAPER; CORONARY ARTERY DISEASE; FAMILIAL DISEASE; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENOTYPE; HEART INFARCTION; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMORPHIC LOCUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL; ARTICLE; CHROMOSOME 1; CHROMOSOME MAP; GENETICS; GENOME; MIDDLE AGED; ONSET AGE;

AGE OF ONSET; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME, HUMAN; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TRIGLYCERIDES;

EID: 50049098131     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700576-JLR200     Document Type: Conference Paper

References (34)

1. s 1. Hokanson, J. E., M. A. Austin, A. Zambon, and J. D. Brunzell. 1993. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler. Thromb. 13: 427-434.
2. Hopkins, P. N., G. Heiss, R. C. Ellison, M. A. Province, J. S. Pankow, J. H. Eckfeldt, and S. C. Hunt. 2003. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 108: 519-523.
3. Hopkins, P. N., L. L. Wu, S. C. Hunt, and E. A. Brinton. 2005. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J. Am. Coll. Cardiol. 45: 1003-1012.
4. Jeppesen, J., H. O. Hein, P. Suadicani, and F. Gyntelberg. 1998. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 97: 1029-1036.
5. Adult Treatment Panel III. 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106: 3143-3421.
6. Cantor, R. M., T. de Bruin, N. Kono, S. Napier, A. van Nas, H. Allayee, and A. J. Lusis. 2004. Quantitative trait loci for apolipo- protein B, cholesterol, and triglycerides in familial combined hyper- lipidemia pedigrees. Arterioscler.Thromb. Vasc.Biol. 24: 1935-1941.
7. Eckel, R. H. 2007. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Proc. Nutr. Soc. 66: 82-95.
8. Krauss, R. M. 1995. Dense low density lipoproteins and coronary artery disease. Am. J. Cardiol. 75: 53B-57B.
9. Shearman, A. M., J. M. Ordovas, L. A. Cupples, E. J. Schaefer, M. D. Harmon, Y. Shao, J. D. Keen, A. L. DeStefano, O. Joost, P. W. Wilson, et al. 2000. Evidence for a gene influencing the TG/ HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham Study. Hum. Mol. Genet. 9: 1315-1320.
10. Dallongeville, J., S. Lussier-Cacan, and J. Davignon. 1992. Modulation of plasma triglyceride levels by apoE phenotype: a meta- analysis. J. Lipid Res. 33: 447-454.
11. Groenendijk, M., R. M. Cantor, T. W. de Bruin, and G. M. Linga- Thie. 2001. The apoAI-CIII-AIVgene cluster. Atherosclerosis. 157: 1-11.
12. Isaacs, A., F. A. Sayed-Tabatabaei, O. T. Njajou, J. C. Witteman, and C. M. van Duijn. 2004. The -514 C-.T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J. Clin. Endocrinol. Metab. 89: 3858-3863.
13. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipo- protein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173.
14. Pennacchio, L. A., and E. M. Rubin. 2003. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler. Thromb. Vasc. Biol. 23: 529-534.
15. Wittrup, H. H., A. Tybjaerg-Hansen, and B. G. Nordestgaard. 1999. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 99: 2901-2907.
16. Shen, G. Q., L. Li, D. Girelli, S. B. Seidelmann, S. Rao, C. Fan, J. E. Park, Q. Xi, J. Li, Y. Hu, et al. 2007. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am. J. Hum. Genet. 81: 780-791.
17. Wang, Q., S. Rao, G. Q. Shen, L. Li, D. J. Moliterno, L. K. Newby, W. J. Rogers, R. Cannata, E. Zirzow, R. C. Elston, et al. 2004. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74: 262-271.
18. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 41-247.
19. Seda, O. 2004. Comparative gene map of hypertriglyceridaemia. Folia Biol. (Praha). 50: 43-57.
20. Newman, D. L., M. Abney, H. Dytch, R. Parry, M. S. McPeek, and C. ber. 2003. Major loci influencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosity-by-descent mapping in a large Hutterite pedigree. Hum. Mol. Genet. 12: 137-144.
21. Elbein, S. C., and S. J. Hasstedt. 2002. Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q. Diabetes. 51: 528-535.
22. Malhotra, A., and J. K. Wolford. 2005. Analysis of quantitative lipid traits in the genetics of NIDDM (GENNID) study. Diabetes. 54: 3007-3014.
23. Arnett, D. K., M. B. Miller, H. Coon, R. C. Ellison, K. E. North, M. Province, M. Leppert, and J. H. Eckfeldt. 2004. Genome-wide linkage analysis replicates susceptibility locus for fasting plasma triglycerides: NHLBI Family Heart Study. Hum. Genet. 115: 468-474.
24. Feitosa, M. E., T. Rice, I. B. Borecki, T. Rankinen, A. S. Leon, J. S. Skinner, J. P. Despres, J. Blangero, C. Bouchard, and D. C. Rao. 2006. Pleiotropic QTL on chromosome 12q23-q24 influences triglyceride and high-density lipoprotein cholesterol levels: the HERITAGE Family Study. Hum. Biol. 78: 317-327.
25. Fujimoto, K., R. Koishi, T. Shimizugawa, and Y. Ando. 2006. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp. Anim. 55: 27-34.
26. Inaba, T., M. Matsuda, M. Shimamura, N. Takei, N. Terasaka, Y. Ando, H. Yasumo, R. Koishi, M. Makishima, and I. Shimomura. 2003. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J. Biol. Chem. 278: 21344-21351.
27. Li, C. 2006. Genetics and regulation of angiopoietin-like proteins 3 and 4. Curr. Opin. Lipidol. 17: 152-156.
28. Shimamura, M., M. Matsuda, H. Yasumo, M. Okazaki, K. Fujimoto, K. Kono, T. Shimizugawa, Y. Ando, R. Koishi, T. Kohama, et al. 2007. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler. Thromb. Vasc. Biol. 27: 366-372.
29. 29.Koishi,R.,Y.Ando,M.Ono,M.Shimamura,H.Yasumo, T. Fujiwara, H. Horikoshi, and H. Furukawa. 2002. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30: 151-157.
30. van der Vleuten, G. M., L. A. Kluijtmans, A. Hijmans, H. J. Blom, A. F. Stalenhoef, and J. de Graaf. 2006. The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia. Int. J. Obes. (Lond). 30: 892-898.
31. Kannenberg, F., P. Ellinghaus, G. Assmann, and U. Seedorf. 1999. Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2/sterol carrier protein-x knockout mice. J. Biol. Chem. 274: 35455-35460.
32. Seedorf, U., M. Raabe, P. Ellinghaus, F. Kannenberg, M. Fobker, T. Engel, S. Denis, F. Wouters, K. W. Wirtz, R. J. Wanders, et al. 1998. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev. 12: 1189-1201.
33. Riddell, D. R., D. V. Vinogradov, A. K. Stannard, N. Chadwick, and J. S. Owen. 1999. Identification and characterization of LRP8 (apoER2) in human blood platelets. J. Lipid Res. 40: 1925-1930.
34. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havulinna,et al. 2008. Six new loci associated with blood low-density lipo- protein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: In press.